SAN JOSE, Calif.—When members of the DeVos family invested $100 million in Theranos Inc. in 2014, they felt like they were part of an exclusive group backing a startup that would change healthcare, jurors heard Tuesday in the criminal-fraud trial of Elizabeth Holmes.
Lisa Peterson, a representative for the DeVos family office, is the second witness to testify about the specific investments listed in the 12-count indictment filed against Ms. Holmes, which charges the Theranos founder with deceiving investors and patients about the capabilities of Theranos’s finger-prick blood-testing technology.